ZMH up +0.89% percent Today $ZMH High is at 111.97 and the

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
ZMH up +0.89% percent Today $ZMH High is at 111.97 and the Low 110.14 with current volume of 90,248.

Recent News posted below.

Zimmer Holdings ZMH other info.
http://investorshangout.com/Zimmer-Holdings-ZMH-53179/

ZMH Zimmer Holdings Recent Headline News

Midday Glance: Medical Devices companies
AP - 12 mins ago
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 111.49 (+0.81), JNJ: 108.98 (+0.68), MDT: 71.86 (+2.67), BAX: 72.38 (+0.38)

EC extends review period for Zimmer/Biomet deal
Seeking Alpha - at Seeking Alpha - 1 hr 15 mins ago

ZMH: 111.49 (+0.81)

Early Glance: Medical Devices companies
AP - Tue Nov 18, 9:23AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 111.49 (+0.81), JNJ: 108.98 (+0.68), MDT: 71.86 (+2.67), BAX: 72.38 (+0.38)

Research and Markets: North America Wound Debridement Devices Market Outlook to 2020: Key Vendors are Smith & Nephew Plc, Zimmer Holdings, Inc. KG, Misonix, Inc. and Soring GmbH
Business Wire - Tue Nov 18, 9:13AM CST
Research and Markets (http://www.researchandmarkets.com/research/m2vlcm/north_america) has announced the addition of the "North America Wound Debridement Devices Market Outlook to 2020" report to their offering.
ZMH: 111.49 (+0.81)

North America Wound Debridement Devices Market Outlook to 2020: Key Vendors are Smith & Nephew Plc, Zimmer Holdings, Inc. KG, Misonix, Inc. and Soring GmbH
M2 - Tue Nov 18, 8:57AM CST
Research and Markets (http://www.researchandmarkets.com/research/4mkrzq/north_america) has announced the addition of the "North America Wound Debridement Devices Market Outlook to 2020" report to their offering. North America Wound Debridement Devices Market Outlook to 2020 provides key market data on the North America Wound Debridement Devices market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments - Hydrosurgical Debridement Devices, Low Frequency Ultrasound Devices and Mechanical Debridement Pads. The report also provides company shares and distribution shares data for each of these market categories, and global corporate-level profiles of the key market participants, pipeline products, and news and deals related to the Wound Debridement Devices market wherever available. The data in the report is derived from dynamic market forecast models. The publisher uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible. Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis. Scope - Annualized market revenues (USD million), volume (units) and average prices (in US dollars) data for each of the market segments. Data is provided from 2005 to 2013 and forecast to 2020. - 2013 company shares and distribution shares data for Wound Debridement Devices market. - Global corporate-level profiles of key companies operating within the North America Wound Debridement Devices. Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Wound Debridement Devices Market, North America 4 Wound Debridement Devices Market, Canada 5 Wound Debridement Devices Market, Mexico 6 Wound Debridement Devices Market, United States 7 Overview of Key Companies in North America Wound Debridement Devices Market 8 Appendix For more information visit http://www.researchandmarkets.com/research/4m...th_america
ZMH: 111.49 (+0.81)

Zimmer Provides Update on the European Commission Review Process Relating to the Pending Merger with Biomet, Inc.
PR Newswire - Tue Nov 18, 6:28AM CST
Zimmer Holdings, Inc. (NYSE and SIX: ZMH) ("Zimmer" announced today that it has agreed with the European Commission (the "EC" to extend the deadline for the EC's review of Zimmer's proposed acquisition of Biomet by a limited number of days in order to provide the EC with certain additional information.
ZMH: 111.49 (+0.81)

MiMedx's Competitive Advantage And Management Execution Charts Path To Future Growth And Shareholder Opportunity
Dave Kelly - at Seeking Alpha - Tue Nov 18, 5:45AM CST

ZMH: 111.49 (+0.81), MDT: 71.86 (+2.67), MDXG: 10.82 (+0.58)

Final Glance: Medical Devices companies
AP - Mon Nov 17, 5:02PM CST
NEW YORK (AP) — Shares of some top medical devices companies were up at the close of trading:
ZMH: 111.49 (+0.81), JNJ: 108.98 (+0.68), MDT: 71.86 (+2.67), BAX: 72.38 (+0.38)

Zimmer's Virage® OCT Spinal Fixation System Wins Life Science Alley Award
PR Newswire - Mon Nov 17, 8:00AM CST
Zimmer Spine, a division of Zimmer Holdings, Inc., (NYSE: ZMH and SIX: ZMH), is one of the 2014 winners of the Life Science Alley (LSA) New Technology Showcase. Zimmer Spine will present at the keynote luncheon at the LSA Health Technology Leadership Conference on November 19. The conference focuses on the policies, business practices and advancements reinventing healthcare. The winning organizations were selected based on the novelty of their technology, its market potential and its ability to improve patient outcomes while lowering per capita healthcare costs.
ZMH: 111.49 (+0.81)

Exactech's (EXAC) Octane Elevate to Advance Spine Surgery - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:15PM CST
Developer of orthopedic implant devices, Exactech Inc. (EXAC), recently announced the launch of Octane Elevate, a self-distracting lumber fusion device made of Poly Ether Ether Ketone (PEEK), a colorless organic thermoplastic polymer.
ZMH: 111.49 (+0.81), GMED: 22.90 (+0.47), EXAC: 21.99 (+0.15), SYK: 89.56 (+1.03)

Globus Medical to Redefine Spinal Fusion with ALTERA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:07PM CST
Manufacturer of musculoskeletal implants, Globus Medical Inc. (GMED), recently announced the launch of ALTERA, which is claimed to be the first minimally intrusive expandable spacer.
ZMH: 111.49 (+0.81), GMED: 22.90 (+0.47), EXAC: 21.99 (+0.15), SYK: 89.56 (+1.03)

Global Single Tooth Implants and Dental Bridges (3-unit, 4-unit, Maryland, Cantilever, Partial) Market - Forecasts to 2019
M2 - Fri Nov 14, 5:21AM CST
Research and Markets (http://www.researchandmarkets.com/research/vvh2gj/single_tooth) has announced the addition of the "Single Tooth Implants and Dental Bridges Market by Product, by Type, by Material - Global Forecasts to 2019" report to their offering. The global single tooth implants and dental bridges market is valued at $3,297.6 million in 2014 and is poised to grow at a CAGR of 7.3% during the forecast period of 2014 to 2019. Rising incidences of dental caries and other periodontal diseases among the aging baby-booming population and growing aging population who are more prone to tooth loss are the major factors driving the growth of this market. In addition, better hygiene and aesthetics associated with the usage of single tooth implants is expected to drive the growth of the single tooth implants, as opposed to dental bridges. The global single tooth implants and dental bridges market is consolidated in nature, with the top five players occupying over 50% share. These companies are adopting strategies such as collaborations, agreements, and new product launches to survive and maintain their market shares in this market. The top five players in this market include STRAUMANN (Switzerland), DENTSPLY International (U.S.), Nobel Biocare Holding AG (Switzerland), Zimmer Holdings (U.S.), and Biomet 3i (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Single Tooth Implants Market, By Value and Global Volume 8 Dental Bridges Market 9 Dental Bridges and Single Tooth Implant Market, By Geography 10 Competitive Landscape 11 Company Profiles Companies Mentioned: - 3M Company - Avinent Implant System - Biomet, Inc. - CAMlog - Danaher Corporation - Dentsply International Inc. - Nobel Biocare Holding AG - Osstem Implant Co., Ltd. - Straumann - Zimmer Holdings Inc. For more information visit http://www.researchandmarkets.com/research/vv...ngle_tooth
ZMH: 111.49 (+0.81), MMM: 159.72 (+1.03), DHR: 82.64 (+0.27), XRAY: 53.07 (+0.46)

Zimmer Spine Showcases its Expanding Business and a Dozen New Products at the 2014 NASS Meeting
PR Newswire - Wed Nov 12, 8:00AM CST
Zimmer Spine, a division of Zimmer Holdings, Inc., (NYSE: ZMH and SIX: ZMH), announced that it will exhibit its expanded spine surgery portfolio at the 2014 North American Spine Society (NASS) meeting in San Francisco, November 12-14 at the Zimmer Spine exhibit booth #1105. In addition, select spine surgeons will share their clinical knowledge regarding the safe and effective use of these new technologies at the Zimmer Spine exhibit booth over the course of the meeting.
ZMH: 111.49 (+0.81)

Global Orthodontic Equipment and Consumables Market 2014-2020
M2 - Wed Nov 12, 3:34AM CST
Research and Markets (http://www.researchandmarkets.com/research/cfsdm4/orthodontic) has announced the addition of the "Orthodontic Equipment and Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" report to their offering. Global orthodontic equipment and consumables market is categorized as equipment and consumables. In 2013, the orthodontic equipment segment accounted for the largest share owing to rising preference for cosmetic dentistry coupled with technological advancements. Dental radiology equipment segment accounted for the largest share in terms of market revenue in 2013. Dominance of this product segment was majorly due to introduction of advanced digital radiography equipment coupled with high cost of the equipment. The global orthodontic consumables segment is expected to grow at the highest growth rate during the forecast period from 2014 to 2020. Of which, self-ligating brackets segment is anticipated to have a healthy growth during the forecast period owing to incessant launch of new brackets with advance technologies. For instance, SL3 Bracket, In-Ovation C, SmartClip and others are some of the commercially available brackets. The global orthodontic equipment and consumables market is dominated by few major players. DENTSPLY International, Inc., A-Dec, Inc., Patterson Companies, Sirona Dental Systems, Inc., Danaher Corporation among others are some of the key players having presence in the global orthodontic equipment and consumables market. These key players are majorly adopting mergers and acquisitions and research and development as the strong growth strategies to expand their geographic presence and introduction of innovative products in the market. Scope of the Report Equipment - CAD/CAM Systems - Dental Chairs - Handpieces - Light Cure - Scaling Unit - Dental Lasers - Dental Radiology Consumables - Anchorage Appliances - - Buccal Tube - - Bands - - Miniscrews - Ligature - - Elastomeric Ligature - - Wire Ligature - Bracket - - Aesthetic Bracket - - Metal Bracket - - Self-Ligating Bracket - Archwires - - Nickel Titanium Archwire - - Stainless Steel Archwire - - Beta Titanium Archwire Companies Mentioned - 3Shape A/S - A-Dec, Inc. - DENTSPLY International, Inc. - Danaher Corporation - GC CORPORATION - Henry Schein, Inc. - Midmark Corporation - Patterson Companies, Inc. - Septodont - Sirona Dental Systems, Inc. - Ultradent Products, Inc. - Zimmer Holdings, Inc. For more information visit http://www.researchandmarkets.com/research/cf...rthodontic
ZMH: 111.49 (+0.81), SIRO: 82.86 (+0.41), DHR: 82.64 (+0.27), HSIC: 131.98 (+1.04), XRAY: 53.07 (+0.46)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sarepta Under Scrutiny: KSF's Investigation Deepens

Updated Category News Views 3

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

Continue Reading
Cyngn: A Deep Dive into Its Robust 24-Patent Portfolio

Updated Category News Views 4

Cyngn's Growing Patent Portfolio: A Robust Defense Ah, Cyngn Inc., the hotshot in AI-powered autonomous vehicle tech, is flexing its muscles with a solid 24-patent stash. We're talking about a company that's not messing around, racking these up since they decided to dive head-first into solving the brain-busting problems of the industrial sector. Their strategy? Build and...

Continue Reading
New Concierge Pediatric Care at Weill Cornell Launches

Updated Category News Views 3

A New Way Forward in Pediatric Care When a couple of seasoned pediatricians decide it's time for something fresh, eyes and ears perk up. Enter Dr. Paul W. Chung and Dr. Jane E. Rosini, diving headfirst into a revolutionary pediatric concierge program courtesy of Concierge Choice Physicians (CCP). We're talking a substantial shake-up at Weill Cornell Medicine, aiming to...

Continue Reading
Postal Service Defends New Rule Amid Speculation

Updated Category News Views 3

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Continue Reading
Acepodia's ACE723 Clears FDA Hurdle for Hepatocellular Push

Updated Category News Views 6

Unexpected Developments from Acepodia Folks keeping a keen eye on the biotech scene might just raise an eyebrow at Acepodia's latest move. The FDA has given their nod to ACE723, an ambitious dual-payload antibody-drug conjugate (ADC) designed to wrangle with those stubborn cases of unresectable or metastatic hepatocellular carcinoma (HCC). This isn't just another day in...

Continue Reading
BellRing Brands Faces Legal Probe; Fiduciary Duties Questioned

Updated Category News Views 1

What's Stirring at BellRing Brands? Hey, no time like the present to dive headfirst into this mess BellRing's found itself in. On the heels of a lackluster sales forecast, just announced about a year ago, Kahn Swick & Foti's got their magnifying glasses out, searching for any shady dealings by those running the show at BellRing Brands, LLC. Why Is BellRing in the Hot...

Continue Reading
S&P 500 Shuffle: Bloom, Illumina, Everpure Join Frenzy

Updated Category News Views 5

Index Shuffles Stir Market Pot Changes are afoot, folks, with the movers and shakers of the market indices stepping into the spotlight. A lot is brewing with S&P Dow Jones Indices making significant switches effective September 21, 2026—right before trading heats up. You better believe it's affecting more than a couple of tickers. Who's In and Who's Out? If you’ve...

Continue Reading
TrailBlazer Magazine Snags a Tribune for In-House Design

Updated Category News Views 4

Who Knew? Design Awards Aren't Just for Pretty Pictures TrailBlazer Magazine gets a pat on the back from GDUSA's 2026 Inhouse Design Awards, a nod to top-notch design work. With over 4,000 entries across the board, getting into the top 10 percent is like finding a steakhouse with zero line on a Friday night. Not exactly common, right? Design Worth Cheering For The winning...

Continue Reading
MMRO Achieves URAC AI Accreditation, Ensures Compliance

Updated Category News Views 4

A Milestone in Healthcare AI: MMRO's New Accreditation When AI in healthcare gets an official nod from the big guys like URAC, it's a significant moment. We're talking about Managed Medical Review Organization, Inc. (MMRO), a firm that's just earned the URAC Artificial Intelligence in Health Care Accreditation. Now, this isn't just some rubber stamp; it's a testament to...

Continue Reading
Dimerix Locks Down A$34M Loan: No Shareholder Dilution

Updated Category News Views 2

Dimerix Grabs Non-Dilutive Funds amid Kidney Trials Here we go with Dimerix's latest move, folks. They roped in A$34 million through a cozy get-together with lenders from Australia and the U.S. What's the kicker? This cash won't touch shareholder equity. So, breathe easy, investors. It's a rare feat to pull off non-dilutive funds these days, especially in the biopharma...

Continue Reading

Top 5 Most Recently Viewed Articles

Transforming the Narcolepsy Market: Innovations Ahead

Updated Category News Views 166

The Evolving Landscape of the Narcolepsy Market The narcolepsy market is undergoing significant changes as it shifts from merely managing symptoms to developing targeted therapies that tackle the root causes of the disorder. Traditionally, treatments focused on alleviating symptoms, but advancements now emphasize addressing the underlying neurochemical issues, primarily...

Continue Reading
UBS Analysts Share Insights on China Stocks Strategies

Updated Category News Views 242

UBS Analysts Offer Insights on China's Equity Market In a recent discussion, UBS strategists have expressed a level of caution regarding China's equity market as they look into the evolving landscape of 2025. It's noted that local A-share investors appear hesitant to seize buying opportunities, influenced by a myriad of factors that create uncertainty in the market....

Continue Reading
Palisade Bio's Special Meeting Cancellation: What You Need to Know

Updated Category News Views 133

Palisade Bio Cancels Special Meeting of Stockholders Palisade Bio, Inc. (Nasdaq: PALI) is a clinical-stage biopharmaceutical company making strides in developing innovative treatments for autoimmune, inflammatory, and fibrotic diseases. Recently, the company announced an important decision regarding its special meeting of stockholders. The special meeting, originally...

Continue Reading
Vivendi Reports Impressive 4.5% Revenue Growth in 2024

Updated Category News Views 123

Remarkable Revenue Growth for Vivendi Vivendi has announced an impressive increase in its revenues for the first nine months of 2024, emphasizing strong growth across its core business sectors. The company reported a revenue increase of 4.5% at constant currency and perimeter, compared to the same period in the previous year. This growth showcases the resilience and...

Continue Reading
Revolution in Home Renovation Arrives with Spray-Net Franchise

Updated Category News Views 226

Fresh Approach to Home Makeovers Home remodeling isn’t just about slapping on a new coat of paint anymore. In February 2026, Spray-Net is gearing up to launch in Allen, Texas, shaking things up in the renovation game. This venture represents a leap forward—not only for franchise growth but for homeowners who are sick and tired of traditional, drawn-out renovations....

Continue Reading